Showing 3681-3690 of 7016 results for "".
Unlocking the Potential of TYK2 Inhibitors in Plaque Psoriasis
https://reachmd.com/programs/frontlines-psoriasis/tyk2-inhibitors-plaque-psoriasis-potential/39952/With high selectivity, durable response, and once-daily dosing, next-generation TYK2 inhibitors offer a promising oral option for patients with moderate-to-severe plaque psoriasis. Ryan Quigley sits down with Dr. Christopher Bunick, Associate Professor of Dermatology and Translational BiomedSpotlight on Asia-Pacific: Practice Beyond Borders
https://reachmd.com/programs/cme/spotlight-on-asia-pacific-practice-beyond-borders/39810/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
https://reachmd.com/programs/cme/doublet-or-triplet-a-case-based-debate-in-first-line-choices-for-hrher2-mbc/39806/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Women in Aesthetics: Fairyal Day
https://reachmd.com/topics/practice-development/women-in-aesthetics-fairyal-day/48886/Get to know Fairyal Day, Founder of Med Talent, Global Medical Search, an executive search firm specializing in the medical aesthetics, dermatology, dental, and pharmaceutical industriesKappa-Opioid Settings: Real-World Evidence Insights
https://reachmd.com/programs/cme/kappa-opioid-settings-real-world-evidence-insights/36300/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Lifestyle Intervention and Bone Quality in Older Adults with Obesity
https://reachmd.com/programs/clinicians-roundtable/program-name/39653/Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
https://reachmd.com/programs/eye-on-ocular-health/imaging-and-proteomics-differentiating-neuropathic-corneal-pain-from-dry-eye/37271/Innovations in IgAN Care: Addressing Challenges with Therapeutic Advances
https://reachmd.com/programs/clinicians-roundtable/innovations-in-igan-care-addressing-challenges-with-therapeutic-advances/37217/The available treatment options and even the current guidelines for the management of IgA nephropathy (IgAN) come with several limitations. Fortunately, new therapies are on the horizon that can help us address those challenges and slow disease progression in IgAN. Here with Dr. Charles Turck to disUnderstanding Who Joined COVID-19 Vaccine Trials and Why
https://reachmd.com/programs/clinicians-roundtable/understanding-who-joined-covid-19-vaccine-trials-and-why/36416/Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
https://reachmd.com/programs/neurofrontiers/timing-matters-influenza-vaccination-response-in-ms-patients-on-ofatumumab/32826/